Philadelphia Pharmaceuticals PLC Stock Forecast for 2023 - 2025 - 2030

Philadelphia Pharmaceuticals PLC Revenue Forecast for 2023 - 2025 - 2030

Philadelphia Pharmaceuticals PLC's Revenue has grown In the last year, rising from 7.70M to 8.40M – a growth of 9.09%. In the following year, 0 experts forecast Philadelphia Pharmaceuticals PLC's Revenue will decrease by 8.33%, to 7.70M. In 2030, professionals predict that Philadelphia Pharmaceuticals PLC's Revenue will decrease by 5.61%, to 7.93M.

Philadelphia Pharmaceuticals PLC Dividend per Share Forecast for 2023 - 2025 - 2030

Philadelphia Pharmaceuticals PLC Free Cash Flow Forecast for 2023 - 2025 - 2030

Philadelphia Pharmaceuticals PLC EBITDA Forecast for 2023 - 2025 - 2030

In the last year, Philadelphia Pharmaceuticals PLC's EBITDA has grown, moving from 780.00k to 1.65M – an increase of 111.54%. According to 0 analysts, Philadelphia Pharmaceuticals PLC's EBITDA will fall by 52.73% in the next year, reaching 779.96k. Professionals believe that By 2030, Philadelphia Pharmaceuticals PLC's EBITDA will fall to 1.31M – a 20.32% decrease from its current value.

Philadelphia Pharmaceuticals PLC EBIT Forecast for 2023 - 2025 - 2030

In the last year, Philadelphia Pharmaceuticals PLC's EBIT has seen an increase, rising from 470.00k to 1.35M. This represents a growth of 187.23%. In the following year, 0 experts forecast that Philadelphia Pharmaceuticals PLC's EBIT will decrease by 65.19%, to 469.94k. In 2030, professionals predict that Philadelphia Pharmaceuticals PLC's EBIT will decrease by 12.23%, to 1.18M.

Philadelphia Pharmaceuticals PLC EPS Price Prediction Forecast for 2023 - 2025 - 2030

Philadelphia Pharmaceuticals PLC's EPS has grown In the last year, rising from 0.00 to 0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach 0.00 – an increase of 100.00%. For the next six years, experts predict that Philadelphia Pharmaceuticals PLC's EPS will grow at a rate of 100.00%.